Russia's RDIF to invest in coronavirus tests developer Medpromresurs
19/03/2020 13:15
MOSCOW, March 19 (Reuters) - The Russian Direct Investment
Fund (RDIF) said on Thursday it will invest in Medpromresurs, a
Russian company that is currently developing coronavirus tests.
RDIF said that its partners in Medpromresurs, established to
focus on a new Russian-Japanese diagnostic system for
coronavirus, are Japan's К.R. Mirai Genomics and two other
Russian firms.
(Reporting by Anton Kolodyazhnyy; writing by Katya Golubkova;
editing by Jason Neely)
((ekaterina.golubkova@thomsonreuters.com; +7 495 775 1242;))